Oxytocin Modulates Osteogenic Commitment in Human Adipose-Derived Stem Cells

Area of Science:

• Stem cell biology
• Endocrinology
• Regenerative medicine

Background:

• Human adipose-derived stem cells (hASCs) are promising for cell therapy due to their accessibility and multipotency.
• Identifying natural molecules to modulate hASC properties is crucial for therapeutic applications.
• Oxytocin (OXT), a neurohypophyseal hormone, influences behavior and well-being.

Purpose of the Study:

• To investigate the effects of Oxytocin (OXT) on human adipose-derived stem cell (hASC) proliferation, migration, senescence, and differentiation.
• To explore the potential role of autophagy in OXT-mediated hASC responses.
• To determine if OXT can enhance osteogenic differentiation of hASCs.

Main Methods:

• Treatment of hASCs with OXT for 72 hours.
• Assessment of hASC proliferation and migration.
• Measurement of senescence-associated β-galactosidase (SA-β-gal) activity.
• Evaluation of osteogenic and adipogenic differentiation using Alizarin red staining and gene/protein expression analysis.
• Analysis of autophagy marker gene expression.

Main Results:

• OXT did not significantly affect hASC proliferation or migratory ability.
• SA-β-galactosidase activity increased, suggesting a role in senescence or autophagy.
• OXT dose-dependently promoted osteogenic differentiation of hASCs.
• OXT did not affect adipogenic differentiation.
• Autophagy marker gene expression increased during OXT-induced osteogenesis.

Conclusions:

• Oxytocin (OXT) promotes osteogenic differentiation in human adipose-derived stem cells (hASCs).
• OXT's effect on osteogenesis may involve the modulation of the autophagic process.
• OXT does not impair hASC proliferation or migration, supporting its potential therapeutic use.